Novartis India Appoints Additional Director, Acknowledges Departing Board Member
Novartis India Ltd. announced several board updates following a meeting held on March 27, 2026. The company appointed Ms. Gowree Gokhale as an Additional Director, designated as a Non-Executive and Independent Director, effective April 1, 2026. Her appointment, recommended by the Nomination and Remuneration Committee, is for a five-year term, extending to March 31, 2031, pending member approval.Ms. Gokhale is a Solicitor with over 30 years of diverse legal experience, specializing in intellectual property, data protection, and consumer protection. She previously co-led the Pharma and Medical Devices practice areas at Nishith Desai Associates and currently leads her own independent chamber practice. She holds an L.L.M from Mumbai University and a Diploma in Taxation Laws from the University of Pune. She is not related to any other director of the company.
The board also acknowledged the completion of the second term of Ms. Sandra Martyres as an Independent Director. Her tenure concludes April 18, 2026. The board expressed gratitude for Ms. Martyres' significant contributions during her time with the company.
A postal ballot will be held to approve Ms. Gokhale’s appointment. The board meeting commenced at 9:30 A.M. (IST) and concluded at 10:00 A.M. (IST).
Table: Details of Ms. Gowree Gokhale’s Appointment
| Particulars | Details |
|---|---|
| Name of the Director | Ms. Gowree Gokhale (DIN:09351661) |
| Reason for change | Appointment as Additional Director |
| Date of appointment | April 1, 2026 |
| Term of Appointment | 5 years, effective April 1, 2026, to March 31, 2031 |
| Brief Profile | Distinguished Solicitor with expertise in intellectual property, data protection, and consumer protection law. |
| Disclosure of relationships | Not related to any director |
Table: Details of Ms. Sandra Martyres’ Departure
| Particulars | Details |
|---|---|
| Name of the Director | Ms. Sandra Martyres (DIN: 00798406) |
| Reason for change | Completion of term as Independent Director |
| Date of cessation | April 18, 2026 |
Source:
Disclaimer: Due care and diligence have been taken in compiling and presenting news and market-related content. However, errors or omissions may arise despite such efforts.
The information provided is for general informational purposes only and does not constitute investment advice, a recommendation, or an offer to buy or sell any securities. Readers are advised to rely on their own assessment and judgment and consult appropriate financial advisers, if required, before taking any investment-related decisions.